{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:17:14Z","timestamp":1793132234393,"version":"4.5.0"},"reference-count":20,"publisher":"American Society of Hematology","issue":"22","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,5,30]]},"abstract":"<jats:title>Key Points<\/jats:title>\n                  <jats:p>Severe thrombocytopenia is rare and major hemorrhage is uncommon in children with persistent and chronic ITP. In children with persistent or chronic ITP, there is a trend toward reserving drug therapy for those experiencing significant bleeding.<\/jats:p>","DOI":"10.1182\/blood-2012-12-466375","type":"journal-article","created":{"date-parts":[[2013,4,2]],"date-time":"2013-04-02T22:44:27Z","timestamp":1364942667000},"page":"4457-4462","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":101,"title":["Bleeding manifestations and management of children with persistent and chronic immune thrombocytopenia: data from the Intercontinental Cooperative ITP Study Group (ICIS)"],"prefix":"10.1182","volume":"121","author":[{"given":"Cindy E.","family":"Neunert","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Georgia Regents University, Augusta, GA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George R.","family":"Buchanan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The University of Texas Southwestern Medical Center, Dallas, TX;"},{"name":"Children\u2019s Medical Center Dallas, Dallas, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Imbach","sequence":"additional","affiliation":[{"name":"Division of Pediatric Oncology-hematology, University Children\u2019s Hospital, Basel, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula H. B.","family":"Bolton-Maggs","sequence":"additional","affiliation":[{"name":"Manchester Royal Infirmary, University of Manchester, Manchester, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn M.","family":"Bennett","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children\u2019s Health Care of Atlanta, Atlanta, GA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellis","family":"Neufeld","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children\u2019s Hospital Boston, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara K.","family":"Vesely","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Epidemiology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Adix","sequence":"additional","affiliation":[{"name":"Children\u2019s Medical Center Dallas, Dallas, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor S.","family":"Blanchette","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"K\u00fchne","sequence":"additional","affiliation":[{"name":"Division of Pediatric Oncology-hematology, University Children\u2019s Hospital, Basel, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"3","key":"2019111819014320900_B1","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1067\/S0022-3476(03)00245-2","article-title":"Duration and morbidity of newly diagnosed idiopathic thrombocytopenic purpura in children: a prospective Nordic study of an unselected cohort.","volume":"143","author":"Rosth\u00f8j","year":"2003","journal-title":"J Pediatr"},{"issue":"11","key":"2019111819014320900_B2","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/00043426-200411000-00007","article-title":"Long-term outcome of chronic idiopathic thrombocytopenic purpura in children.","volume":"26","author":"Jayabose","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"issue":"suppl 5","key":"2019111819014320900_B3","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/pbc.20995","article-title":"Idiopathic thrombocytopenic purpura: a 15-year natural history study at the Children\u2019s Hospital Rijeka, Croatia.","volume":"47","author":"Roganovic","year":"2006","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"2019111819014320900_B4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/MPH.0b013e3180320b36","article-title":"Chronic immune thrombocytopenic purpura in children: a survey of the Canadian experience.","volume":"29","author":"Belletrutti","year":"2007","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"2019111819014320900_B5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/pbc.20453","article-title":"Childhood ITP: 12 months follow-up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS).","volume":"46","author":"Imbach","year":"2006","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"2019111819014320900_B6","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1067\/S0022-3476(03)00535-3","article-title":"A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group.","volume":"143","author":"K\u00fchne","year":"2003","journal-title":"J Pediatr"},{"issue":"10","key":"2019111819014320900_B7","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1182\/blood-2008-03-138487","article-title":"Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura.","volume":"112","author":"Neunert","year":"2008","journal-title":"Blood"},{"issue":"1","key":"2019111819014320900_B8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V88.1.3.3","article-title":"Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology.","volume":"88","author":"George","year":"1996","journal-title":"Blood"},{"issue":"4","key":"2019111819014320900_B9","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1046\/j.1365-2141.2003.04131.x","article-title":"Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy.","volume":"120","author":"British Committee for Standards in Haematology General Haematology Task Force","year":"2003","journal-title":"Br J Haematol"},{"issue":"9078","key":"2019111819014320900_B10","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0140-6736(97)04143-3","article-title":"Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines.","volume":"350","author":"Bolton-Maggs","year":"1997","journal-title":"Lancet"},{"issue":"suppl 1","key":"2019111819014320900_B11","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1097\/00043426-200312001-00011","article-title":"Severe bleeding in idiopathic thrombocytopenic purpura.","volume":"25","author":"Bolton-Maggs","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"2019111819014320900_B12","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/pbc.21872","article-title":"Demographic data, natural history, and prognostic factors of idiopathic thrombocytopenic purpura in children: a multicentered study from Argentina.","volume":"52","author":"Donato","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"2019111819014320900_B13","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/pbc.21916","article-title":"Comparison of idiopathic thrombocytopenic purpura in children between 3 months and 2 years versus 2-5 years.","volume":"52","author":"Kalyoncu","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"2019111819014320900_B14","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1651-2227.2012.02671.x","article-title":"Duration and morbidity of chronic immune thrombocytopenic purpura in children: five-year follow-up of a Nordic cohort.","volume":"101","author":"Rosth\u00f8j","year":"2012","journal-title":"Acta Paediatr"},{"issue":"2","key":"2019111819014320900_B15","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1365-2141.2009.07743.x","article-title":"Possible lower rate of chronic ITP after IVIG for acute childhood ITP an analysis from registry I of the Intercontinental Cooperative ITP Study Group (ICIS).","volume":"146","author":"Tamminga","year":"2009","journal-title":"Br J Haematol"},{"issue":"2","key":"2019111819014320900_B16","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1182\/blood-2009-06-225565","article-title":"International consensus report on the investigation and management of primary immune thrombocytopenia.","volume":"115","author":"Provan","year":"2010","journal-title":"Blood"},{"issue":"16","key":"2019111819014320900_B17","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1182\/blood-2010-08-302984","article-title":"The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia.","volume":"117","author":"Neunert","year":"2011","journal-title":"Blood"},{"issue":"2","key":"2019111819014320900_B18","first-page":"281","article-title":"Effect of a single dose of rituximab in chronic immune thrombocytopenic purpura in childhood.","volume":"90","author":"Taube","year":"2005","journal-title":"Haematologica"},{"issue":"4","key":"2019111819014320900_B19","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/pbc.21978","article-title":"Relationships among bleeding severity, health-related quality of life, and platelet count in children with immune thrombocytopenic purpura.","volume":"53","author":"Neunert","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"2019111819014320900_B20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/adc.2010.184234","article-title":"Changing trends in the UK management of childhood ITP.","volume":"97","author":"Grainger","year":"2012","journal-title":"Arch Dis Child"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/22\/4457\/1365775\/4457.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/22\/4457\/1365775\/4457.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T19:03:43Z","timestamp":1574103823000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/121\/22\/4457\/31351\/Bleeding-manifestations-and-management-of-children"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,30]]},"references-count":20,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2013,5,30]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-12-466375","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,30]]}}}